Drug maker GlaxoSmithKline PLC said Wednesday it would lay off hundreds of its US workers to reduce costs and to streamline its research and drugmarketing operations by the end of  The layoffs which focus on the companys North Carolina site are the latest of many job cuts in the pharmaceutical sector in recent years driven by patent expirations for bigselling drugs and efforts to outsource more research and development A GlaxoSmithKline spokeswoman attributed the companys moves to market changes evolving customer
  